Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Rheumatic Disease ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Classification criteria in rheumatic diseases: a review of methodologic properties.Arthritis Rheum. 2007; 57: 1119-1133
- Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort.Arthritis Care Res (Hoboken). 2022; 74: 1575-1584
- Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients.Medicine (Baltimore). 2014; 93: 73-81
- The effect of male sex on survival in systemic sclerosis.J Rheumatol. 2014; 41: 2193-2200
- Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.Arthritis Res Ther. 2016; 18: 30
- Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis.J Rheumatol. 2009; 36: 787-793
- Ethnic variations in systemic sclerosis disease manifestations, internal organ involvement, and mortality.J Rheumatol. 2019; 46: 1103-1108
- Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.J Rheumatol. 2006; 33: 1117-1122
- Mortality and causes of death in a Swedish series of systemic sclerosis patients.Ann Rheum Dis. 1998; 57: 682-686
- Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma).Br J Rheumatol. 1998; 37: 750-755
- Distinctions between diagnostic and classification criteria?.Arthritis Care Res. 2015; 67: 891-897
- Classification criteria for rheumatic diseases: why and how?.Arthritis Rheum. 2007; 57: 1112-1115
- Classification in systemic sclerosis.J Rheumatol. 2006; 33: 840-841
- Systematic analysis of the literature in search of defining systemic sclerosis subsets.J Rheumatol. 2021; 48: 1698-1717
- Classification criteria for systemic sclerosis subsets.J Rheumatol. 2007; 34: 1855-1863
- 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.Arthritis Rheum. 2013; 65: 2737-2747
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Ann Rheum Dis. 2013; 72: 1747-1755
- New classification criteria for systemic sclerosis (Scleroderma).Rheum Dis Clin North Am. 2015; 41: 383-398
- New ACR EULAR guidelines for systemic sclerosis classification.Curr Rheumatol Rep. 2015; 17: 32
- Validation of potential classification criteria for systemic sclerosis.Arthritis Care Res. 2012; 64: 358-367
- Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.J Clin Epidemiol. 2014; 67: 706-714
- Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.Arthritis Care Res. 2012; 64: 351-357
- A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases.Clin Exp Rheumatol. 2013; 31: 24-30
- Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.Arthritis Rheum. 1980; 23: 581-590
- Preliminary criteria for the classification of systemic sclerosis (scleroderma).Bull Rheum Dis. 1981; 31: 1-6
- The diagnosis and classification of scleroderma (systemic sclerosis).Postgrad Med J. 1988; 64: 121-125
- Methods and preliminary results of the scleroderma criteria cooperative study of the American Rheumatology Association.Clin Rheum Dis. 1979; 5: 27-48
- Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice.Rheumatology (Oxford). 2015; 54: 1454-1458
- The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group.Arthritis Care Res (Hoboken). 2015; 67: 582-587
- Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.J Rheumatol. 2015; 42: 60-63
- Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.Semin Arthritis Rheum. 2016; 46: 350-355
- The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.Arthritis Rheum. 2007; 57: 203-212
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.J Rheumatol. 1988; 15: 202-205
- Limited cutaneous systemic sclerosis: the unfairly neglected subset.J Scleroderma Relat Disord. 2016; 1: 241-246
- Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.Ann Rheum Dis. 2011; 70: 476-481
- Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis.Ann Rheum Dis. 2013; 72: 319-321
- Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.Ann Rheum Dis. 2014; 73: 2087-2093
- Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum.Clin Exp Rheumatol. 2020; 38: 40-47
- ANCA-associated vasculitis in systemic sclerosis report of 3 cases.Rheumatol Int. 2013; 33: 139-143
- Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome.J Rheumatol. 2018; 45: 1406-1410
- Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification.J Pediatr. 1983; 103: 882-888
- Calcinosis biomarkers in adult and juvenile dermatomyositis.Autoimmun Rev. 2020; 19: 102533
- Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids.Eur J Paediatr Neurol. 1998; 2: 205-211
- Management of calcinosis cutis in rheumatic diseases.J Rheumatol. 2022; 49: 980-989
- Performance of juvenile scleroderma classification criteria for juvenile systemic sclerosis. results from the jssc inception cohort.Arthritis Rheumatol. 2017; 69: 1777-1778
- Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? clinical characteristics of a juvenile systemic sclerosis cohort.J Scleroderma Relat Disord. 2018; 4: 49-61
- Controversies: molecular vs. clinical systemic sclerosis classification.J Scleroderma Relat Disord. 2016; 1: 277-285
- Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope.Ann Rheum Dis. 2001; 60: 407-409
- Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). an immunogenetic, serologic, and clinical analysis.Arthritis Rheum. 1996; 39: 1151-1160
- Genetics of scleroderma: implications for personalized medicine?.BMC Med. 2013; 11: 9
- Moving towards a molecular taxonomy of autoimmune rheumatic diseases.Nat Rev Rheumatol. 2018; 14: 180
- Antibody pattern and other criteria for diagnosis and classification of PSS.J Rheumatol. 1988; 15: 153-154
- Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.Rheumatology (Oxford). 2004; 43: 719-726
- Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.J Rheumatol. 2000; 27: 155-160
- Autoantibodies in systemic sclerosis.Semin Arthritis Rheum. 2005; 35: 35-42
- A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.Clin Exp Rheumatol. 2013; 31: 118-121
- Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Curr Opin Rheumatol. 2014; 26: 646-652
- Cutaneous and serologic subsets of systemic sclerosis.J Rheumatol. 1991; 18: 1826-1832
- The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis.Rheumatology (Oxford). 2003; 42: 534-540
- Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.Medicine (Baltimore). 2016; 95: e4713
- Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.Arthritis Care Res. 2014; 66: 575-584
- American College of Rheumatology Ad Hoc Committee of Immunologic Testing G. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies.Arthritis Rheum. 2003; 49: 399-412
- Circulating anti-nuclear antibodies in systemic sclerosis: utility in diagnosis and disease subsetting.J Nippon Med Sch. 2017; 84: 56-63
- Antinuclear antibody-negative systemic sclerosis.Semin Arthritis Rheum. 2015; 44: 680-686
- Molecular subsets in the gene expression signatures of scleroderma skin.PLoS One. 2008; 3: e2696
- Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis.J Invest Dermatol. 2013; 133: 1979-1989
- Nail fold capillaroscopy: normal findings in children and adolescents.Semin Arthritis Rheum. 1999; 29: 36-42
- Nailfold videocapillaroscopy in healthy children and adolescents: description of normal patterns.Clin Exp Rheumatol. 2016; 34: 193-199
- Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.Rheumatology (Oxford). 2017; 56: 1081-1088
- Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis.Clin Rheumatol. 2006; 25: 453-457
- Nailfold digital capillaroscopic findings in patients with diffuse and limited cutaneous systemic sclerosis.Reumatologia. 2017; 55: 15-23
- Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.Medicine (Baltimore). 2002; 81: 154-167
- Progress in the clinical classification of systemic sclerosis.Curr Opin Rheumatol. 2017; 29: 568-573
- There is a need for new systemic sclerosis subset criteria. a content analytic approach.Scand J Rheumatol. 2018; 47: 62-70
- A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.J Rheumatol. 1988; 15: 276-283
- Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.J Rheumatol. 2010; 37: 2071-2075
- Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis.J Rheumatol. 2011; 38: 702-705
- Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).J Rheumatol. 2000; 27: 1196-1202
- South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.Int J Rheum Dis. 2012; 15: 102-109
- The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.Br J Dermatol. 2008; 158: 487-495
- Anticentromere-A and anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis.J Rheumatol. 2010; 37: 2548-2552
- Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.Clin Exp Immunol. 1999; 117: 395-402
- New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.J Rheumatol. 2013; 40: 461-468
- Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.J Rheumatol. 2012; 39: 787-794
- Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.Arthritis Rheum. 2005; 52: 2425-2432
- Anticentromere antibody. clinical correlations and association with favorable prognosis in patients with scleroderma variants.Arthritis Rheum. 1983; 26: 1-7
- Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.Arthritis Rheum. 1994; 37: 248-252
- Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome.Clin Rev Allergy Immunol. 2007; 32: 47-56
- Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.J Rheumatol. 1986; 13: 911-916
- Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.J Rheumatol. 2007; 34: 1528-1534
- Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.Rheumatology (Oxford). 2009; 48: 1570-1574
- Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.Acta Reumatol Port. 2009; 34: 219-227
- Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.Int Immunol. 2009; 21: 415-422
- Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.Clin Exp Rheumatol. 2017; 35: 98-105
- To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?.Clin Exp Rheumatol. 2018; 36: 109-117
- Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis.Rheumatol Adv Pract. 2018; 2: rky002
- Antinuclear autoantibody profile in systemic sclerosis patients who are negative for anticentromere and anti-topoisomerase I specificities.Joint Bone Spine. 2015; 82: 209-210
- Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.Eur J Intern Med. 2013; 24: 868-871
- Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.Ann Rheum Dis. 2018; 77: 1179-1186
- Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.Int J Rheum Dis. 2017; 20: 1572-1581
- Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.Arthritis Rheumatol. 2015; 67: 1045-1052
- Proteomic analysis of sera from individuals with diffuse cutaneous systemic sclerosis reveals a multianalyte signature associated with clinical improvement during imatinib mesylate treatment.J Rheumatol. 2017; 44: 631-638
- RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.Int J Dermatol. 2016; 55: 882-885
- Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis.Arthritis Res Ther. 2013; 15: R72
- Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.Autoimmunity. 2015; 48: 542-551
- Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.Arthritis Rheum. 2010; 62: 2787-2795
- Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study.Clin Exp Rheumatol. 2014; 32: S-177-182
- Protective effect against cancer of antibodies to the large subunits of both RNA polymerases I and III in scleroderma.Arthritis Rheumatol. 2019; 71: 1571-1579
- Mixed connective tissue disease.Mod Rheumatol. 2019; 13: 11-18
- Interpretation of an extended autoantibody profile in a well-characterized australian systemic sclerosis (scleroderma) cohort using principal components analysis.Arthritis Rheumatol. 2015; 67: 3234-3244
- Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.Medicine (Baltimore). 2016; 95: e3931
- Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis.Rheumatology (Oxford). 2015; 54: 2100-2107
- Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.Clin Exp Rheumatol. 2015; 33: S131-S135
- Disease-related autoantibody profile in patients with systemic sclerosis.Autoimmunity. 2017; 50: 414-421
Article info
Publication history
Published online: March 01, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
